FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis

Annals of Neurology

Volumn 67, Issue 6, 2010, Pages 739-748

  Deng, Han Xiang ^a   Zhai, Hong ^a   Bigio, Eileen H ^a   Yan, Jianhua ^a   Fecto, Faisal ^a   Ajroud, Kaouther ^a   Mishra, Manjari ^a   Ajroud Driss, Senda ^a   Heller, Scott ^a   Sufit, Robert ^a   Siddique, Nailah ^a   Mugnaini, Enrico ^a   Siddique, Teepu ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; PROTEIN; PROTEIN FUS; PROTEIN P62; TAR DNA BINDING PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; DEMENTIA; FAMILIAL DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MUTATION; NERVE CELL DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL; SPINAL CORD; SPINAL CORD VENTRAL HORN;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; CELL LINE, TRANSFORMED; DNA-BINDING PROTEINS; FAMILY HEALTH; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; INCLUSION BODIES; MALE; MICROSCOPY, CONFOCAL; MUTATION; RNA-BINDING PROTEIN FUS; RNA-BINDING PROTEINS; SUPEROXIDE DISMUTASE; TRANSFECTION; UBIQUITIN;

EID: 77952932485     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22051     Document Type: Article

References (31)

1. Deng HX, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 1993;261:1047-1051. (Pubitemid 23300865)
2. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 199;362:59-62.
3. Kabashi E, Valdmanis PN, Dion P, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008;40:572-574.
4. Sreedharan J, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008; 319:1668-1672.
5. Van Deerlin VM, Leverenz JB, Bekris LM, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 2008;7:409-416.
6. Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 2006;7: 710-723. (Pubitemid 44267495)
7. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009;323:1205-1208.
8. Vance C, Rogelj B, Hortobagyi T, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009;323:1208-1211.
9. Belzil VV, Valdmanis PN, Dion PA, et al. Mutations in FUS cause FALS and SALS in French and French Canadian populations. Neurology 2009;73:1176-1179.
10. Corrado L, Del Bo R, Castellotti B, et al. Mutations of FUS Gene in Sporadic Amyotrophic Lateral Sclerosis. J Med Genet 2010; 47:190-194.
11. Drepper C, Herrmann T, Wessig C, et al. C-terminal FUS/TLS mutations in familial and sporadic ALS in Germany. Neurobiol Aging [published online ahead of print December 15, 2009].
12. Groen EJ, van Es MA, van Vught PW, et al. FUS mutations in familial amyotrophic lateral sclerosis in the Netherlands. Arch Neurol 2010;67:224-230.
13. Lai SL, Abramzon Y, Schymick JC, et al. FUS mutations in sporadic amyotrophic lateral sclerosis. Neurobiol Aging [published online ahead of print February 4, 2010].
14. Tateishi T, Hokonohara T, Yamasaki R, et al. Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation. Acta Neuropathol 2010;119:355-364.
15. Lansbury PT, Lashuel HA. A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 2006; 443:774-779.
16. Leigh PN, Whitwell H, Garofalo O, et al. Ubiquitinimmunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 1991; 114(pt 2):775-788.
17. Lowe J. New pathological findings in amyotrophic lateral sclerosis. J Neurol Sci 1994;124(suppl):38-51.
18. Shibata N, Hirano A, Kobayashi M, et al. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 1996;55: 481-490. (Pubitemid 26112102)
19. Mackenzie IR, Bigio EH, Ince PG, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 2007;61: 427-434.
20. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-133.
21. Deng HX, Shi Y, Furukawa Y, et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc Natl Acad Sci U S A 2006;103:7142-7147.
22. Deng HX, Jiang H, Fu R, et al. Molecular dissection of ALS-associated toxicity of SOD1 in transgenic mice using an exonfusion approach. Hum Mol Genet 2008;17:2310-2319.
23. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994;264:1772-1775. (Pubitemid 24227760)
24. Nakano T, Nakaso K, Nakashima K, Ohama E. Expression of ubiquitin-binding protein p62 in ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis with dementia: analysis of five autopsy cases with broad clinicopathological spectrum. Acta Neuropathol 2004;107:359-364. (Pubitemid 38477363)
25. Neumann M, Rademakers R, Roeber S, et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 2009;132(pt 11):2922-2931.
26. Neumann M, Roeber S, Kretzschmar HA, et al. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol 2009;118:605-616.
27. Lagier-Tourenne C, Cleveland DW. Rethinking ALS: the FUS about TDP-43. Cell 2009;136:1001-1004.
28. Munoz DG, Neumann M, Kusaka H, et al. FUS pathology in basophilic inclusion body disease. Acta Neuropathol 2009;118: 617-627.
29. Andersson MK, Stahlberg A, Arvidsson Y, et al. The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell typespecific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol 2008;9:37.
30. Buratti E, Baralle FE. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci 2008; 13:867-878. (Pubitemid 351594732)
31. Hicks GG, Singh N, Nashabi A, et al. Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet 2000;24:175-179. (Pubitemid 30094720)